Medical Properties Trust (MPW) Today: Rating Upgrade, Institutional Moves & Q3 Turnaround

Medical Properties Trust, Inc. (NYSE: MPW) remains one of the most closely watched high‑yield REITs on Wall Street. As of mid‑November 2025, the stock sits around the $5 mark, backed by a dividend yield of roughly 6–7% and a long list of past controversies involving distressed tenants like Steward Health Care and Prospect Medical. ^[1]

Today’s news cycle brings two fresh catalysts for MPW investors:

A rating upgrade from Wall Street Zen, moving MPW from “sell” to “hold.” ^[2]
New regulatory filings showing that Bank of New York Mellon Corp trimmed its stake in the REIT by 1.7% in Q2 2025. ^[3]

At the same time, investors are still digesting MPW’s Q3 2025 results, released on October 30, which showed an improving cash‑collection picture but another GAAP net loss as the company works through legacy tenant issues. ^[4]

Key current metrics:

Share price: about $4.95 per share (latest trade, mid‑November 2025) ^[5]
Market capitalization: roughly $3.0 billion ^[6]
52‑week range: approximately $3.51 – $6.34 ^[7]
Dividend: quarterly payout of $0.08 per share, implying a forward yield around 6.4% at current prices ^[8]
Leverage & liquidity: debt‑to‑equity of about 2.0x and a current/quick ratio of 2.76, signaling decent near‑term liquidity but a still‑heavy debt load. ^[9]

MPW remains a special‑situation high‑yield REIT: potentially attractive income, but still tethered to the outcomes of tenant restructurings and regulatory scrutiny.

Fresh Headlines Today: Rating Upgrade and Institutional Rebalancing

Wall Street Zen upgrades MPW to “Hold”

In today’s most notable development, Wall Street Zen, as reported via MarketBeat, upgraded Medical Properties Trust from a “sell” rating to a “hold” rating. ^[10]

That move comes against a mixed backdrop of broader analyst opinions:

Weiss Ratings keeps MPW at a “sell (D‑)” as of early October. ^[11]
Wells Fargo maintains an “underweight” stance with a $4.50 price target, trimmed from $5.00. ^[12]
Zacks Research has upgraded the stock from “strong sell” to “hold.” ^[13]

According to MarketBeat’s compiled data, the consensus picture currently looks like this:

1 Buy
4 Hold
2 Sell
Overall rating: “Reduce”
Average price target: about $5.40 per share. ^[14]

In other words, today’s upgrade nudges sentiment closer to neutral but does not signal a broad analyst stampede into bullish territory.

Bank of New York Mellon trims its MPW stake

Also dated today, new 13F data summarized by MarketBeat show Bank of New York Mellon Corp reduced its MPW position by 1.7% in Q2 2025. ^[15]

Key details:

BNY Mellon sold 110,955 MPW shares during the quarter.
It now holds about 6.25 million shares of the REIT. ^[16]

This is a modest trim rather than an exit, but institutional flows matter for a stock like MPW that is still rebuilding confidence after a painful multi‑year drawdown.

Q3 2025 Results: Improving Cash Collections, Ongoing GAAP Loss

MPW released its Q3 2025 earnings on October 30, 2025, along with its Form 10‑Q filed on November 7. ^[17]

Headline numbers for Q3 2025

For the quarter ended 30 September 2025:

Total revenue:$237.5 million, up from $225.8 million a year earlier (about 5% year‑over‑year growth). ^[18]
GAAP net loss to common shareholders:–$77.7 million, or –$0.13 per share. ^[19]
Normalized Funds From Operations (NFFO):$0.13 per share, according to the company’s press release. ^[20]

MarketBeat notes that this $0.13 figure came in below consensus analyst expectations of $0.16, while revenue of $237.5 million was also a bit under the roughly $244.9 million Street estimate. ^[21]

The gap between negative GAAP earnings and positive FFO is largely driven by non‑cash impairment charges.

Prospect impairments still weigh on GAAP earnings

MPW’s Q3 net loss included approximately $82 million in impairment charges, mostly connected to transactions tied to its troubled tenant Prospect Medical Group, which is going through bankruptcy. ^[22]

Those impairments:

Depress GAAP earnings.
Do not fully reflect the ongoing cash rent being received from replacement operators.
Highlight how much the REIT remains exposed to legacy distressed tenants even as properties are re‑leased.

Cash rent collections are trending in the right direction

On the more positive side, MPW emphasized that cash rents from new tenants are largely current:

Cash rents from new tenants were fully current through October, except for three facilities in Ohio and Pennsylvania.
Overall, MPW reported 96% of scheduled cash rent collected. ^[23]
Cash collections on certain problem assets improved from $11 million in Q2 to $16 million in Q3, with management expecting about $22 million in Q4 2025 (excluding a one‑off rent payment received on October 1). ^[24]

Several third‑party analyses — including pieces from ChartMill and TipRanks — echoed the theme of operational progress amid headline GAAP losses, highlighting the stronger NFFO and improving collection trends despite ongoing impairment charges. ^[25]

$150 Million Share Buyback and a Still‑Rich Dividend

Strategic share repurchase program

Alongside its Q3 results, Medical Properties Trust’s board authorized a $150 million common stock repurchase program, framed as a “strategic” buyback initiative. ^[26]

Analysts at Simply Wall St and other platforms have noted that such buybacks at depressed share prices can:

Signal management confidence in intrinsic value.
Provide a supportive bid for the stock, enhancing per‑share metrics. ^[27]

However, critics question whether a heavily leveraged REIT facing tenant issues should prioritize repurchases over deleveraging.

Dividend: high yield, lower growth

MPW declared a $0.08 per share quarterly dividend in Q3 2025, consistent with its reduced payout following earlier cuts. ^[28]

Key dividend facts:

Annualized dividend: $0.32 per share based on the current $0.08 quarterly rate.
At roughly $5 per share, that implies a forward yield near 6.4–6.5%. ^[29]
Three‑year dividend growth has been negative, with an average reduction of around 18% per year over that period, reflecting the reset after tenant issues. ^[30]

Dividend trackers such as DividendMax estimate that the next ex‑dividend date is expected in mid‑December 2025, with payment projected for early January 2026, although future declarations remain at the board’s discretion. ^[31]

The upshot: MPW still offers headline yield, but it is not the stable, steadily growing payout it once was.

Tenant Fallout: Steward & Prospect Still Shape the Story

Medical Properties Trust’s last few years have been defined by the collapse or distress of key tenants — particularly Steward Health Care and Prospect Medical.

Steward Health Care: bankruptcy and settlement

Steward Health Care filed for Chapter 11 bankruptcy in May 2024 with around $9+ billion in liabilities. ^[32]
By mid‑2025, nearly all of Steward’s 29 hospitals across eight states had been sold or transferred to new operators under a court‑approved plan, much of it negotiated under a global settlement that included landlord Medical Properties Trust. ^[33]
Separately, commentary from policy analysts and state‑level reporting has spotlighted the role of sale‑leaseback deals and REIT‑style financial engineering in Steward’s collapse, increasing scrutiny on MPW’s business model. ^[34]

Earlier, in 2024, MPW disclosed that it had taken control of certain Steward‑leased real estate and signed new lease agreements with multiple replacement operators to stabilize operations at 15 hospitals. ^[35]

Prospect Medical: impairments and ongoing restructuring

Prospect Medical’s bankruptcy has been another major headache:

MPW’s Q3 2025 results included ~$82 million in impairments tied primarily to Prospect‑related transactions. ^[36]
Investigative reporting has linked some Prospect hospital struggles to aggressive sale‑leaseback transactions with REITs such as MPW, contributing to elevated fixed costs for already‑struggling operators. ^[37]

Advocacy groups and policy researchers have also flagged instances where MPT has stepped in to finish hospital construction or maintain facilities while searching for new operators, underscoring both the company’s operational role and the complexity of unwinding troubled deals. ^[38]

Political and regulatory pressure

On the political front, scrutiny is intensifying:

On the one‑year anniversary of Steward’s bankruptcy, U.S. Senators Elizabeth Warren and Ed Markey renewed calls for accountability for Steward’s former CEO and executives at Medical Properties Trust, urging regulators and tax authorities to clamp down on REIT structures perceived as extracting value from struggling hospitals. ^[39]

For investors, that means MPW’s story is no longer just about rent checks and cap rates — it’s increasingly about regulatory risk and the public perception of hospital‑focused REITs.

What Analysts and Commentators Are Saying Now

Recent commentary shows the market is far from unanimous on MPW.

The cautiously optimistic camp

A Seeking Alpha piece titled “Medical Properties Trust: Accelerating Recovery Justifies A Rating Upgrade” argues that improving cash rent collection and ramping contributions from new operators support a more constructive stance on the stock. ^[40]
Simply Wall St highlights the $150 million buyback, rising short‑term returns (around 24–26% over the past 90 days and year‑to‑date), and recovering valuation as signs that sentiment may be turning more positive. ^[41]
Zacks notes that MPW shares have risen 16–26% over the last three months, while still trading well below prior highs, framing the REIT as a potential turnaround and income play. ^[42]

These voices generally focus on:

Rising NFFO and cash rent.
The discount to historical valuations.
The possibility that “the worst is behind” with key tenants.

The skeptical camp

On the other hand:

Another Seeking Alpha contributor recently published “Medical Properties Trust: Reiterate Sell – Warning Signs Flashing,” emphasizing continued tenant risk, leverage, and the potential that recent gains could prove fragile. ^[43]
The consensus rating compiled by MarketBeat still ranks MPW as “Reduce”, not “Buy,” even after today’s upgrade. ^[44]
Credit and policy watchers remain wary of REIT‑hospital sale‑leaseback structures, particularly where state oversight is weak and operators are thinly capitalized. ^[45]

In short, MPW appears to be transitioning from “uninvestable” in many eyes to “controversial hold” — but not yet to broad consensus buy.

Key Metrics and Risks to Watch Into 2026

For readers tracking MPW into 2026, here are the main watch‑items:

Cash collections and rent coverage
- Are cash rent collections from restructured and replacement tenants continuing to rise?
- Do rent coverage ratios (EBITDARM coverage) improve across the portfolio?
Progress on tenant restructurings
- Further updates on Prospect and remaining Steward‑related properties.
- Success in re‑leasing or disposing of distressed assets without heavy additional impairments.
Leverage and capital allocation
- Does MPW prioritize debt reduction over aggressive buybacks?
- How quickly does net debt trend down from the current ~$9.6 billion range? ^[46]
Dividend sustainability
- Can MPW maintain its $0.08 quarterly dividend while still funding capex, debt service, and restructuring costs?
- Any sign of further cuts would likely be viewed very negatively by income‑focused holders.
Regulatory and political developments
- Watch for new state‑level rules on hospital sale‑leasebacks and ownership reporting.
- Federal or state investigations into prior deals or tax treatment could affect both MPW and its peers. ^[47]

Bottom Line: A Gradual Turnaround With Real Risks Attached

As of 16 November 2025, Medical Properties Trust sits at a crossroads:

Positives
- Improving cash rent collections and a still‑solid NFFO run‑rate.
- A $150 million buyback and high dividend yield that appeal to value and income investors.
- A stock price still below long‑term levels, despite strong gains over the last several months.
Negatives
- Ongoing GAAP losses driven by impairment charges and high interest costs.
- Significant leverage and dependence on successful tenant turnarounds.
- Political and regulatory scrutiny that could change the economics of hospital REITs over time.

For now, the market’s message — reinforced by today’s upgrade to “Hold” rather than “Buy” — is that MPW may no longer be a clear avoid, but it also isn’t out of the woods. ^[48]

Anyone considering MPW should treat it as a higher‑risk, turnaround‑style REIT and carefully weigh the rich yield and potential upside against the real possibility of further volatility, impairments, or policy shocks.

Disclaimer: This article is for informational purposes only and does not constitute investment, tax, or legal advice. Always do your own research and consider consulting a licensed financial advisor before making investment decisions.

Mizuho's Jared Holz: Here's why healthcare stocks are under pressure